Biomarker

Something measurable in the body, such as a blood or poo test result, that gives information about disease or how it might behave. CRP and faecal calprotectin are examples.

Also called: biomarkers, marker, inflammatory marker, inflammation markers

Related words faecal calprotectin c-reactive protein treat to target

Topics Research Monitoring Diagnosis and tests

Questions people ask

What blood tests are used for Crohn's?

NICE's guidance for GPs suggests a full blood count (to look for anaemia and other signs), inflammation markers such as CRP and ESR, kidney and liver tests including albumin, iron, B12, folate and vitamin D levels, and a coeliac test to rule that out. Crohn's & Colitis UK explains that CRP rises with inflammation but can be normal even when the gut is inflamed, so blood tests are used alongside other tests rather than on their own.

Sources

Why do I still need tests when I feel well?

Symptoms do not always match what is happening inside. Crohn's & Colitis UK says calprotectin can be raised even without symptoms, and tests check for anaemia and medicine side effects. Some teams use a 'treat to target' approach, aiming for healing of the gut lining and normal markers rather than just fewer symptoms. Monitoring may include blood and poo tests, scans, colonoscopy and, in some hospitals, home calprotectin kits.

Sources

What is a faecal calprotectin test?

It is a test on a small sample of poo that measures calprotectin, a protein released by white blood cells when the gut is inflamed. NICE recommends it to help doctors tell IBD apart from IBS. A high result suggests inflammation that needs looking into, but infections and some other conditions can raise it too. It is also used to monitor Crohn's once diagnosed.

Sources

What is the CDAI, and how is it different from the HBI?

The Crohn's Disease Activity Index (CDAI) is an older, longer score. It needs a 7-day symptom diary, your weight and a blood test result, so it takes more effort to work out. A CDAI under 150 is taken as a marker of remission and over 450 as a marker of severe Crohn's. The Harvey-Bradshaw Index is a simpler score based on just the previous day's symptoms and does not need a blood test.

Sources

What does 'treat to target' mean?

It means your team agrees goals in advance and adjusts treatment until you reach them, rather than waiting for symptoms. The STRIDE-II expert agreement says early goals are feeling better and getting blood and poo inflammation tests back to normal; longer-term goals are a healed bowel lining, no disability, good quality of life and normal growth in children. The CALM trial found that stepping up treatment when tests showed inflammation, not just when symptoms flared, led to more bowel healing.

Sources

Where to read more

Outcomes and Strategies to Support a Treat-to-target Approach in Inflammatory Bowel Disease: A Systematic Review

Journal of Crohn's and Colitis via PubMed Central Systematic review Feb 2020 For professionals

Reviews the evidence for 'treat to target', where treatment is adjusted not just to symptoms but to measured goals such as a healed bowel lining and normal blood or poo markers. It explains the idea behind the STRIDE targets and notes that firm proof that aiming for healing improves long-term outcomes was still emerging.

Topics Monitoring Research

Jargon explained treat to target mucosal healing biomarker STRIDE

A biomarker-stratified comparison of top-down versus accelerated step-up treatment strategies for patients with newly diagnosed Crohn's disease (PROFILE)

The Lancet Gastroenterology & Hepatology Study May 2024 Patients and professionals

A large UK-led trial of 386 newly diagnosed adults. Starting straight away with infliximab plus an immunosuppressant ('top-down') kept 79% in remission without steroids or surgery for a year, compared with 15% using the usual 'step-up' approach of trying milder drugs first. There were also fewer flares, serious side effects and operations. A blood test meant to predict who needed strong treatment did not help. Free to read in full.

Topics Biologics and newer medicines Research About Crohn's disease

Jargon explained top-down treatment step-up treatment biomarker steroid-free remission top-down step-up immunomodulator randomised controlled trial

STRIDE-II: An Update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD)

Gastroenterology Guideline Apr 2021 For professionals

An international expert agreement on what 'treat to target' should aim for in IBD. Short-term goals are feeling better and getting blood and poo inflammation tests back to normal. Long-term goals include a healed bowel lining seen at endoscopy, no disability, a normal quality of life, and normal growth in children. Healing through the full bowel wall in Crohn's is not yet a formal target but is a sign of deeper remission.

Topics Monitoring Research Medicines

Jargon explained treat to target endoscopic healing transmural healing biomarker calprotectin CRP clinical remission

Crohn's disease: How should I investigate a person with suspected Crohn's disease?

NICE CKS Guide May 2024 For professionals

Lists the tests a GP may arrange when Crohn's is suspected: a full blood count, inflammation markers (CRP and ESR), kidney and liver tests including albumin, iron, B12, folate and vitamin D levels, a coeliac blood test, poo samples to rule out infection, and faecal calprotectin in adults. It notes that these results can be normal even when Crohn's is active, so normal results do not rule it out.

Topics Diagnosis and tests

Jargon explained full blood count C-reactive protein erythrocyte sedimentation rate albumin faecal calprotectin coeliac disease stool culture

Fecal calprotectin as an inflammatory biomarker in small bowel Crohn disease

Porto Biomedical Journal via PubMed Central Study Jul 2024 For professionals

A study of 196 people with Crohn's affecting only the small bowel, comparing calprotectin levels with capsule endoscopy findings. Calprotectin matched the camera findings only moderately and no cut-off was reliable enough on its own, supporting the point that a normal calprotectin does not rule out small bowel inflammation.

Topics Diagnosis and tests Monitoring

Jargon explained faecal calprotectin capsule endoscopy small bowel

Effect of tight control management on Crohn's disease (CALM): a multicentre, randomised, controlled phase 3 trial

The Lancet Study Dec 2017 Patients and professionals

CALM compared deciding treatment on symptoms alone with 'tight control', where treatment was stepped up if blood or poo tests (CRP and faecal calprotectin) showed inflammation even when people felt fine. After 48 weeks, 46% in the tight control group had a healed bowel lining compared with 30% in the symptom-only group. It is a cornerstone of the 'treat to target' approach.

Topics Monitoring Biologics and newer medicines Research

Jargon explained tight control faecal calprotectin CRP mucosal healing treat to target

Faecal Calprotectin Test

Northern Lincolnshire and Goole NHS Foundation Trust Leaflet Dec 2025 For patients

A hospital leaflet explaining the calprotectin poo test, which shows whether there is inflammation in the gut and is used both to help diagnose and to monitor conditions such as IBD. It explains how to collect the sample and warns that anti-inflammatory painkillers such as ibuprofen can affect the result, so ask your doctor before stopping or continuing them.

Topics Diagnosis and tests Monitoring

Jargon explained faecal calprotectin NSAIDs

Tests and investigations

Crohn's & Colitis UK Guide Dec 2025 For patients

A detailed guide to the tests used to diagnose and monitor Crohn's and colitis: blood tests (full blood count, CRP, liver and kidney tests), poo tests including faecal calprotectin and FIT, endoscopies with tips on bowel prep, capsule endoscopy and the dummy patency capsule, and X-rays, CT, MRI and ultrasound. It explains what results can and cannot tell you, for example that calprotectin can be normal during a flare in the small bowel.

Topics Diagnosis and tests Monitoring

Jargon explained full blood count C-reactive protein faecal calprotectin faecal immunochemical test colonoscopy gastroscopy capsule endoscopy patency capsule biopsy bowel preparation

Faecal calprotectin diagnostic tests for inflammatory diseases of the bowel (HTG320, formerly DG11)

NICE Guideline Oct 2013 For professionals

NICE's recommendation that a faecal calprotectin poo test can be used to help doctors tell IBD apart from IBS. For adults with recent lower gut symptoms it applies when cancer is not suspected and proper quality checks and local pathways are in place; it is also recommended for children with suspected IBD who have been referred to a specialist. This guidance was first published as DG11 and NICE has since renumbered it HTG320 without changing it.

Topics Diagnosis and tests

Jargon explained faecal calprotectin inflammatory bowel disease irritable bowel syndrome

Guide to managing an IBD Flare: My Crohn's and Ulcerative Colitis

University College London Hospitals NHS Foundation Trust Guide For patients

A step-by-step hospital guide for patients: check whether it is a flare (more frequent or loose poo, new mild tummy pain, small amounts of bleeding, feeling generally worse), get blood and poo tests such as faecal calprotectin, then contact the IBD advice line. It says to call 111 or go to A&E or urgent care if symptoms are worse than those described.

Topics Flare-ups Urgent help Diagnosis and tests

Jargon explained flare-up faecal calprotectin crp

Search everything for "biomarker"